Federal Grants for Health



Department of Health and Human Services $62,853,680,968 Department of Transportation $56,443,571,981 Environmental Protection Agency $35,751,587,496 Department of Energy $24,661,368,000 National Aeronautics and Space Administration $14,032,768,821 Department of Homeland Security $13,986,266,741 Department of Labor $10,348,285,755 Department of Defense $10,111,366,675 Department of the Interior $9,806,569,960 Department of Agriculture $8,296,397,040 Agency for International Development $7,754,781,106 Department of Commerce $6,871,103,950 Department of Housing and Urban Development $6,642,477,476 Department of State $6,042,701,916 Department of Justice $5,571,395,802 Department of Education $2,642,831,221 Department of the Treasury $1,019,380,000 Other Agencies $724,036,487


Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National cancer Institute (NCI) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies...more
Posted On - 2024-11-22


Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic...more
Posted On - 2024-11-22


Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Institutes of Health
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic...more
Posted On - 2024-11-22




Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal...more
Posted On - 2024-11-22


Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

National Institutes of Health
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic...more
Posted On - 2024-11-22


Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline...more
Posted On - 2024-11-22


Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal...more
Posted On - 2024-11-22

People Building Stronger Communities


Civic Engagement in the 21st Century

Celebrating World Breastfeeding Week

Senate Appropriations Bill to Provide Funds to Low-Income and Disadvantaged Students

Massachusetts in Deep Crunch to End Homelessness

National Area Preservation Holds Volunteer Workday to Honor MLK

Illinois Stifles Funding for Human Services Nonprofits

Alternative Service Break Group Heads to California

Angel Investor Ron Conway Targets Homelessness

White House Roundtable Results to Abacus Impact Investing Commitments

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

National Institutes of Health
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic...more
Posted On - 2024-11-22


NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

National Institutes of Health
The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research...more
Posted On - 2024-11-21



<< Previous 9 Announcements
Next 9 Announcements >>


Social Entrepreneurship
Spotlight



When it Comes to Social Enterprises, Failure is the Best Platform for Innovation


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.


Grant Scams?

Learn How to Identify and Avoid Grant Scams




More Federal Domestic Assistance Programs


PPHF 2012 Public Health Laboratory Infrastructure financed solely by 2012 Prevention and Public Heal | Promotion of the Humanities_Fellowships and Stipends | School Improvement Grants | Educational Exchange_Congress-Bundestag Youth Exchange | Community Trade Adjustment Assistance |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders
© 2004-2025 Copyright Michael Saunders